This article first appeared on GuruFocus.

DocGo Inc (NASDAQ:DCGO) is set to release its Q3 2025 earnings on Nov 10, 2025. The consensus estimate for Q3 2025 revenue is $69.77 million, and the earnings are expected to come in at -$0.12 per share. The full year 2025's revenue is expected to be $317.56 million, and the earnings are expected to be -$0.47 per share. More detailed estimate data can be found on the Forecast page.

Warning! GuruFocus has detected 3 Warning Signs with DCGO.

Is DCGO fairly valued? Test your thesis with our free DCF calculator.

Revenue estimates for DocGo Inc (NASDAQ:DCGO) have increased from $316.31 million to $317.56 million for the full year 2025 and declined from $318.65 million to $316.11 million for 2026 over the past 90 days. Earnings estimates have declined from -$0.37 per share to -$0.47 per share for the full year 2025 and declined from -$0.13 per share to -$0.18 per share for 2026 over the past 90 days.

In the previous quarter of 2025-06-30, DocGo Inc's (NASDAQ:DCGO) actual revenue was $80.42 million, which beat analysts' revenue expectations of $77.57 million by 3.67%. DocGo Inc's (NASDAQ:DCGO) actual earnings were -$0.11 per share, which missed analysts' earnings expectations of -$0.09 per share by -17.02%. After releasing the results, DocGo Inc (NASDAQ:DCGO) was up by 12.95% in one day.

Based on the one-year price targets offered by 6 analysts, the average target price for DocGo Inc (NASDAQ:DCGO) is $3.08 with a high estimate of $4.00 and a low estimate of $1.60. The average target implies an upside of 188.73% from the current price of $1.07.

Based on GuruFocus estimates, the estimated GF Value for DocGo Inc (NASDAQ:DCGO) in one year is $2.35, suggesting an upside of 120.66% from the current price of $1.07.

Based on the consensus recommendation from 7 brokerage firms, DocGo Inc's (NASDAQ:DCGO) average brokerage recommendation is currently 2.3, indicating an \\"Outperform\\" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.